GeoPark Reports Fourth Quarter and Full-Year 2020 Results yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
CHAIR ANNOUNCEMENT
The Board of Directors of Royal Dutch Shell plc (the Company ) has announced the appointment of Sir Andrew Mackenzie as the new Company Chair with effect from the conclusion of Shell’s 2021 Annual General Meeting, scheduled for May 18, 2021. Andrew will succeed Chad Holliday who will step down on May 18 having served as Chair for six years and as a Board Director since September 2010.
Andrew Mackenzie, a British national, joined Shell’s Board in October 2020, after a distinguished career in the energy, petrochemicals and resources sector, latterly as Group CEO of BHP from 2013 to 2019. From 2004 to 2007, at Rio Tinto, he was Head of Industrial Minerals and Diamonds. Prior to this, over a 22-year career at BP, he held senior leadership roles in exploration, research and development, and chemicals. His contributions to geochemistry and earth science led to his appointment as a Fellow of the Royal Society in 2014, and he received a knighthood in 2020 for his
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
VivoPower International PLC Announces Contract to Complete Electrical Works for 200 MW Blue .
VivoPower International PLCMarch 10, 2021 GMT
LONDON, March 10, 2021 (GLOBE NEWSWIRE) VivoPower International PLC (NASDAQ: VVPR, the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, J.A. Martin Electrical Pty Limited (“J.A. Martin”) has recently been awarded a contract to complete all electrical works for the 200 MW Blue Grass Solar Farm located near the town of Chinchilla in the Australian state of Queensland. The project will be the third Australian solar farm completed by J.A. Martin in partnership with lead EPC contractor GRS and brings J.A. Martin’s total of completed and contracted solar farms to over 350 MWdc.
Published: Mar 11, 2021
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces its submission to G-BA (Gemeinsamer Bundesausschuss) for approval of sugarBEAT
®, the Company’s non-invasive, daily wear, continuous glucose monitoring device.
The G-BA is the highest decision-making body for joint self-administration in the German health care system, determining medical services that insured people can claim as well as resolving quality assurance measures for practices and hospitals. The G-BA’s primary function is specifying the “service catalog” of the health insurance companies according to the generally recognized state of medical knowledge. Should it be approved for reimbursement, Nemaura would work with German
Infosys BPM the business process management arm of Infosys today announced a five-year extension to its strategic collaboration with Newmont Corporation , the world's largest gold mining company, to standardize and digitize delivery models across its mine sites. Through this renewed engagement, Infosys BPM will drive operational excellence leveraging automation, artificial intelligence and design thinking, to .